30:825 -Letters to the Editor that secondary failure, thus defined, preferably affects lean patients and not overweight or obese patients [2]; in addition, only lean patients have a significant reduction of C-peptide release, at fasting, 6 rain after intravenous glucagon, and post-prandially. We now present data concerning the HLA phenotype in 74 out-patients with Type 2 diabetes (39 on OHA, 35 on insulin because of secondary failure to OHA, aged 57.9 +__ 1.4, age at onset of diabetes 45.7 + 1.4, duration of disease 12.2 + 0.8 years).
2. Pontiroli AE, Calderara A, BonisoUi L, Maffi P, Alberetto M, Secchi A, Caviezel F, Radaelli G, Gallus G, Pozza G (1986) Body weight as a marker for early secondary failure to oral hypoglycaemic agents in type 2 diabetes. 
Insulin immunology in mono-component insulin treated patients
Dear Sir, I read with appreciation and interest a review by Drell and Notkins [1] of immunological abnormalities in Type I (insulin-dependent) diabetes. The authors find an incidence in the literature of 40%-50% blastogenesis to insulin in Type 1 diabetes and also an absence of response of the resting lymphocyte to insulin.
Our published data [2] reported non-responsiveness to monocomponent insulins in 29 diabetic patients regardless of therapeutic insulin used, compared to control subjects; and in 12 mono-component insulin treated patients using B component of insulin as antigen there was no significant difference, but there was a significant stimulation (transformation index 1.8, p < 0.01) observed in the non monocomponent treated patients. We concluded that insulin per se was non antigenic and that the pro-insulin contained in the non-monocomponent insulin preparations had presensitised the lymphocytes of those diabetic patients.
An observation in our studies [2] not referred to in this review [1] , is the stimulatory effect of zinc on blastogenesis, bearing in mind the zinc content of insulin. Our studies did not observe any difference in transformation comparing zinc with insulins in diabetic patients, but in one group of control subjects we noted a very definite stimulatory effect of zinc compared with B component (zinc transformation index 1.52, n=6; B component transformation index 1.01, n=6; 0.02 <p < 0.05). We believe that attention must be paid to the previous insulin therapy of patients and to the constituents of the stimu-lating insulin preparations used in interpreting data of insulin blastogenesis.
Yours sincerely, J. G. Devlin
More on the role of insulin in the treatment of diabetic ketoacidosis
Dear Sir, Jakobsen et al. [1] have provided valuable experimental support for the postulate that insulin plays a pathogenetic role in two of the complications resulting from the treatment of diabetic ketoacidosis (DKA)-namely the adult respiratory distress syndrome (ARDS) or its more benign counterpart, a widening of the A-a O2 gradient, and cerebral oedema, usually "benign" and very rarely fatal [2, 3] .
Insulin has previously been shown to result in a large decrease in plasma volume and a reduction in the plasma albumin pool when administered intravenously to diabetic patients who were not ill [4] . Furthermore, insulin is known to be capable of decreasing renal sodium excretion by enhancing sodium reabsorption in the diluting segment of the distal nephron [5] and resulting in major fluid and sodium retention in previously uncontrolled diabetic patients [6] -so called "insulin oedema".
It is evident that most adults [7] and probably, children [8] develop subclinical or "benign" cerebral oedema [3] during the course of therapy for DKA.
We have previously described ARDS developing during the treatment of severe DKA [2, 9] . One of the survivors in our most recent series [9] had his insulin therapy inadvertantly delayed for some 3 h after admission. It was this serendipitous occurrence which suggested insulin as a possible pathogenetic factor in ARDS as well as cerebral oedema developing the treatment of DKA.
An additional piece of supporting clinical information derives from the review by Arem and Zoghbi [10] describing 8 patients with massive insulin overdoses. Two of their eight cases plus an additional two cases from their literature review demonstrated ARDS. Furthermore, we have recently treated an elderly woman who had fatal hypoglycaemia secondary to the use of chlorpropamide who developed ARDS shortly after admission to the hospital.
Yours sincerely, R. Matz
